BlinkLab
Announcements

Read our recent announcements about our company, our research, and partnerships.

Rush University Medical Center Joins BlinkLab’s Pivotal U.S. Autism Diagnostic Trial

BlinkLab announces Rush as eighth premier U.S. autism center for F1DA 510(k) trial of smartphone-based diagnostic aid, with first expected subjects in Q1 2026.

Henk-Jan Boele, MD PhD

•

November 13, 2025

In the news

View all

December 28, 2025

As the ASX enters 2025's final quarter, growth stocks with high insider ownership present a compelling case for investors seeking resilience and innovation.

Read the article

December 22, 2025

BlinkLab (ASX:BB1) Henk-Jan Boele, CEO & Co-Founder presents at The Stock Network's ASX Gems investment conference on 19 December 2025.

Read the article

December 2, 2025

WA telehealth startup BlinkLab says smartphone autism app is the answer to Perth’s paediatrician crisis

Read the article

December 1, 2025

BlinkLab nearing FDA liftoff

Read the article

Read all announcements

Rush University Medical Center Joins BlinkLab’s Pivotal U.S. Autism Diagnostic Trial

BlinkLab announces Rush as eighth premier U.S. autism center for F1DA 510(k) trial of smartphone-based diagnostic aid, with first expected subjects in Q1 2026.

Henk-Jan Boele, MD PhD

•

Nov 13, 2025

Pilot Study Confirms High Diagnostic Accuracy and Readiness for FDA Trial

BlinkLab Dx 1 achieved 83.7% sensitivity and 84.7% specificity in a clinically diverse pediatric population, confirming robust real-world diagnostic performance.

Henk-Jan Boele, MD PhD

•

Oct 22, 2025

BlinkLab Adds University of Missouri’s Thompson Center as Sixth Clinical Site for FDA Trial

Marking another step toward FDA clearance for its autism diagnostic tool.

Sophie Linotte

•

Sep 17, 2025

Two additional strategic partnerships with top ranked U.S. institutions advance BlinkLab’s FDA submission

Partnerships with Leading Pediatric Institutions Strengthen BlinkLab’s U.S. Trial Network

Sophie Linotte

•

Sep 16, 2025

BlinkLab Onboards University of Pennsylvania Perelman School of Medicine

BlinkLab onboards Ivy League institution Perelman School as Third Clinical Site for its FDA 510(k) Diagnostic Trial

Henk-Jan Boele, MD PhD

•

Aug 21, 2025

How Exercise Boosts Learning: Insights from Associative Conditioning

Exploring the link between acute aerobic activity, brain function, and learning potential in regular and non-regular exercisers

Peter Boele, MA

•

Jan 14, 2025

Positive outcome received from a Pre-Submission meeting with the FDA regarding the regulatory pathway for BlinkLab Dx 1 diagnostic app.

BlinkLab is thrilled to share the successful outcome of its Pre-Submission meeting with the FDA, marking a critical step toward achieving 510(k) clearance for its innovative autism diagnostic app, BlinkLab Dx 1. With the study design and data requirements now confirmed, BlinkLab is poised to initiate a robust clinical program that will pave the way for regulatory approval and market entry in the US.

Henk-Jan Boele, MD PhD

•

Dec 19, 2024

Improving kids autism and ADHD diagnoses through BlinkLab collaboration with Monash University

BlinkLab partners with Monash University for a two-year MAGNET project to enhance autism and ADHD diagnosis using app-based AI technology.

Peter Boele, MA

•

Nov 21, 2024

BlinkLab partners with Mental Care Group in Europe to improve and accelerate the diagnostic evaluation of ADHD

BlinkLab is thrilled to partner with Mental Care Group (MCG) to advance ADHD diagnosis through smartphone-based digital sensory phenotyping. By integrating BlinkLab’s innovative app into its diagnostic processes, MCG aims to enhance accuracy, efficiency, and accessibility in ADHD assessments, offering a transformative approach for patients and healthcare providers alike.

Henk-Jan Boele, MD PhD

•

Jul 30, 2024

Want to feature BlinkLab?

We are more than happy to assist you with that. If you need any assets, insights or want to request an interview — feel free to reach out to Henk-Jan, our CEO.

Send Henk-Jan an email

BlinkLab
Announcements

Rush University Medical Center Joins BlinkLab’s Pivotal U.S. Autism Diagnostic Trial

In the news

As the ASX enters 2025's final quarter, growth stocks with high insider ownership present a compelling case for investors seeking resilience and innovation.

BlinkLab (ASX:BB1) Henk-Jan Boele, CEO & Co-Founder presents at The Stock Network's ASX Gems investment conference on 19 December 2025.

WA telehealth startup BlinkLab says smartphone autism app is the answer to Perth’s paediatrician crisis

BlinkLab nearing FDA liftoff

Read all announcements

Rush University Medical Center Joins BlinkLab’s Pivotal U.S. Autism Diagnostic Trial

Pilot Study Confirms High Diagnostic Accuracy and Readiness for FDA Trial

BlinkLab Adds University of Missouri’s Thompson Center as Sixth Clinical Site for FDA Trial

Two additional strategic partnerships with top ranked U.S. institutions advance BlinkLab’s FDA submission

BlinkLab Onboards University of Pennsylvania Perelman School of Medicine

How Exercise Boosts Learning: Insights from Associative Conditioning

Positive outcome received from a Pre-Submission meeting with the FDA regarding the regulatory pathway for BlinkLab Dx 1 diagnostic app.

Improving kids autism and ADHD diagnoses through BlinkLab collaboration with Monash University

BlinkLab partners with Mental Care Group in Europe to improve and accelerate the diagnostic evaluation of ADHD

Want to feature BlinkLab?

Help us improve diagnostic evaluations for autism!

Awesome! You're now signed up.

BlinkLabAnnouncements

Rush University Medical Center Joins BlinkLab’s Pivotal U.S. Autism Diagnostic Trial

In the news

As the ASX enters 2025's final quarter, growth stocks with high insider ownership present a compelling case for investors seeking resilience and innovation.

BlinkLab (ASX:BB1) Henk-Jan Boele, CEO & Co-Founder presents at The Stock Network's ASX Gems investment conference on 19 December 2025.

WA telehealth startup BlinkLab says smartphone autism app is the answer to Perth’s paediatrician crisis

BlinkLab nearing FDA liftoff

Read all announcements

Rush University Medical Center Joins BlinkLab’s Pivotal U.S. Autism Diagnostic Trial

Pilot Study Confirms High Diagnostic Accuracy and Readiness for FDA Trial

BlinkLab Adds University of Missouri’s Thompson Center as Sixth Clinical Site for FDA Trial

Two additional strategic partnerships with top ranked U.S. institutions advance BlinkLab’s FDA submission

BlinkLab Onboards University of Pennsylvania Perelman School of Medicine

How Exercise Boosts Learning: Insights from Associative Conditioning

Positive outcome received from a Pre-Submission meeting with the FDA regarding the regulatory pathway for BlinkLab Dx 1 diagnostic app.

Improving kids autism and ADHD diagnoses through BlinkLab collaboration with Monash University

BlinkLab partners with Mental Care Group in Europe to improve and accelerate the diagnostic evaluation of ADHD

Want to feature BlinkLab?

Help us improve diagnostic evaluations for autism!

Join our newsletter!

Awesome! You're now signed up.

BlinkLab
Announcements